Table 2.
Summary of equivalence assessment in 20 subjects: pharmacokinetic characteristics of theophylline (350 mg twice daily) at steady-state. Data are point estimates with 90 percnt; confidence intervals in parentheses.
Summary of equivalence assessment in 20 subjects: pharmacokinetic characteristics of theophylline (350 mg twice daily) at steady-state. Data are point estimates with 90 percnt; confidence intervals in parentheses.